Produktname:6'-Chloro[1(2H),3'-bipyridin]-2-one
IUPAC Name:6'-chloro-2H-[1,3'-bipyridin]-2-one
- CAS:2062643-94-9
- Molekulare Formel:C10H7ClN2O
- Reinheit:95%+
- Katalognummer:CM1078117
- Molekulargewicht:206.63
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2062643-94-9
- Molekulare Formel:C10H7ClN2O
- Schmelzpunkt:-
- SMILES-Code:O=C1C=CC=CN1C2=CN=C(Cl)C=C2
- Dichte:1.377±0.06 g/cm3
- Katalognummer:CM1078117
- Molekulargewicht:206.63
- Siedepunkt:407.5±45.0 °C
- Mdl-Nr.:
- Lagerung:
Category Infos
- Pyridines
- Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
- Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
- Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
- Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.
Column Infos
- AZD0780
- AstraZeneca announced Phase I trial data for its PCSK9 inhibitor, AZD0780. AZD0780 is an oral small molecule PCSK9 inhibitor as a first-in-class therapy for patients with dyslipidemia that cannot be controlled by statins alone. PSCK9 is a well-known and validated target in lipid metabolism and inhibiting PSCK9 signalling has shown to be effective in reducing LDL cholesterol levels in plasma. Lower LDL-C levels are associated with a reduction in the risk of long-term cardiovascular disease and major cardiovascular events.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.